Frontier Wealth Management LLC - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.45 and the average weighting 1.1%.

Quarter-by-quarter ownership
Frontier Wealth Management LLC ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$40,000
-54.0%
13,0990.0%0.00%
+200.0%
Q1 2022$87,000
-20.2%
13,0990.0%0.00%
-85.7%
Q4 2021$109,000
+12.4%
13,0990.0%0.01%0.0%
Q3 2021$97,000
+9.0%
13,0990.0%0.01%
+16.7%
Q2 2021$89,000
-34.1%
13,0990.0%0.01%
-40.0%
Q1 2021$135,000
-28.9%
13,099
-51.7%
0.01%
-37.5%
Q4 2020$190,000
-14.0%
27,0990.0%0.02%
-20.0%
Q3 2020$221,000
+18.2%
27,0990.0%0.02%
+17.6%
Q2 2020$187,000
+45.0%
27,0990.0%0.02%
-19.0%
Q1 2020$129,000
-45.6%
27,0990.0%0.02%
-44.7%
Q4 2019$237,000
+163.3%
27,0990.0%0.04%
+192.3%
Q3 2019$90,000
-32.8%
27,0990.0%0.01%
-35.0%
Q2 2019$134,000
-20.2%
27,0990.0%0.02%
-13.0%
Q1 2019$168,000
+84.6%
27,0990.0%0.02%
+64.3%
Q4 2018$91,000
-48.3%
27,0990.0%0.01%
-17.6%
Q3 2018$176,000
-15.4%
27,0990.0%0.02%
-43.3%
Q2 2018$208,000
-65.7%
27,0990.0%0.03%
-64.7%
Q1 2018$606,00027,0990.08%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders